Back
YieldMax NVDA Option Income Strategy ETF Vs. Corcept Therapeutics Industry Stock Comparison
Sell
44
NVDY
YieldMax NVDA Option Income Strategy ETF
Last Price:
23.25
Seasonality Move:
-0.36%
Buy
74
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Sell
44
YieldMax NVDA Option Income Strategy ETF (NVDY)
is a Sell
Is YieldMax NVDA Option Income Strategy ETF a Buy, Sell or Hold?
- The current YieldMax NVDA Option Income Strategy ETF [NVDY] share price is $23.21. The Score for NVDY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- NVDY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $40.92. The Score for CORT is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVDY Stock Price Chart
What is YieldMax NVDA Option Income Strategy ETF's stock price today?
-
The YieldMax NVDA Option Income Strategy ETF share price today is $23.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVDY is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $40.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
NVDY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.61 | Sell |
Relative Strength Index (14 RSI): | 45.58 | Sell |
Chaikin Money Flow: | -1066481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.56 - 25.44) | Sell |
Bollinger Bands (100): | (24 - 29) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 72.34 | Buy |
Chaikin Money Flow: | -986948 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.51 - 37.97) | Buy |
Bollinger Bands (100): | (28.35 - 36.03) | Buy |
NVDY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.91 | Buy |
20-day SMA: | 23.65 | Sell |
50-day SMA: | 24.8 | Sell |
200-day SMA: | 25.98 | Sell |
8-day EMA: | 23.03 | Buy |
20-day EMA: | 23.48 | Sell |
50-day EMA: | 24.69 | Sell |
200-day EMA: | 25.46 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.22 | Buy |
20-day SMA: | 36.07 | Buy |
50-day SMA: | 35.08 | Buy |
200-day SMA: | 28.51 | Buy |
8-day EMA: | 38.83 | Buy |
20-day EMA: | 36.86 | Buy |
50-day EMA: | 34.93 | Buy |
200-day EMA: | 30.16 | Buy |
YieldMax NVDA Option Income Strategy ETF Earnings Growth & NVDY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
YieldMax NVDA Option Income Strategy ETF Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |